Vigil Neuroscience Inc (VIGL)
7.20
-0.47 (-6.13%)
USD |
NASDAQ |
Aug 19, 16:00
7.30
+0.10 (+1.39%)
After-Hours: 20:00
Vigil Neuroscience Cash from Investing (TTM): -0.367M for June 30, 2022
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2022 | -0.367M |
March 31, 2022 | -0.346M |
Date | Value |
---|---|
December 31, 2021 | -0.204M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.367M
Minimum
Jun 2022
-0.204M
Maximum
Dec 2021
-0.3057M
Average
-0.346M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
EyePoint Pharmaceuticals Inc | -89.55M |
Cidara Therapeutics Inc | -0.112M |
Rhythm Pharmaceuticals Inc | 178.53M |
Magenta Therapeutics Inc | -34.23M |
Allakos Inc | 191.47M |